WO2005123187A1 - Compuesto de circonio y magnetita para tratamiento energetico - Google Patents
Compuesto de circonio y magnetita para tratamiento energetico Download PDFInfo
- Publication number
- WO2005123187A1 WO2005123187A1 PCT/MX2004/000039 MX2004000039W WO2005123187A1 WO 2005123187 A1 WO2005123187 A1 WO 2005123187A1 MX 2004000039 W MX2004000039 W MX 2004000039W WO 2005123187 A1 WO2005123187 A1 WO 2005123187A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- magnetite
- zirconium
- energy
- total
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/06—Magnetotherapy using magnetic fields produced by permanent magnets
Definitions
- the technical field in which the present invention is used is natural alternative medicine and may be applied to any living being in the treatment of any disease or discomfort.
- Magnetic energy is a great force in our entire Universe and only on the basis of the constant research and practice of the use of such energy can we achieve new tools on the road to the full recovery of health.
- the resistance of the human being is the result of its own specific energy potential, which will try to adapt by modifying its magnetic field to achieve balance.
- the energy of life is the balance of positive and negative energies and we can consider this as the alignment of our magnetic field. From the perspective that biomagnetism is based on the very nature of life, applicable to various systems based on the flow of energy, several scientists have spread the use of magnetic energy to cure a myriad of diseases or ailments.
- Magnetic energy has a predominant place in the studies of biomagnetism, because when this energy is applied correctly on the body it gives relief to countless ailments. It is known that when we get sick the energy does not flow properly through our body, so it has been called an energy imbalance, that is, the energy does not flow in the proportion required for the proper performance of our activities.
- the invention that concerns us here and that part of the principles already explained, serves precisely, in a natural, simple and economic, to align our magnetic field, since the mixture of the elements with which this compound provides the magnetic energy necessary for the restoration of the magnetic field and the flow of energy and therefore the restoration of health, regardless of the condition or condition concerned.
- Magnetic fields reduce the pain of inflammations and susceptibility to infections.
- the invention at hand, aligner of our magnetic field is mainly composed of zirconium silicate in sand and pure magnetite mixed and ground in a compound of drinking water with salt and bentonite, the latter as a binder, contained in a small plastic bag for application by contact on a certain part of the body depending on the disease, illness or discomfort.
- Zirconium (or Zirconium) is a chemical-metallic element of atomic number 40 located in group 4 of the periodic table and its symbol is Zr.
- the most important minerals in which it is found are the zircon and the badeleyta. In its pure state, zirconium exists in two forms: the crystalline form, a soft, white and ductile metal; and the amorphous form, a bluish black powder. Both forms are insoluble in water.
- the zirconium never find udder in nature; It exists mainly as silicate, in the mineral zircon, and as an oxide, in the mineral badeleyta.
- the zirconium used for the preparation of the invention must invariably be in its crystalline form due to its ductility.
- Magnetite is a mineral formed primarily by ferrous ferric oxide and contains a high percentage of iron. It occurs in dense, fragile and black masses. Magnetite has magnetic properties and usually appears in the form of granules in almost all igneous stones, but sometimes it accumulates in large masses.
- the magnetite that will be used in the present invention must be perfectly aligned in its magnetic field, that is, it must coincide with the earth's magnetic field and align perfectly to the north.
- Bentonite which is a clay composed essentially of minerals from the smectite group, usually volcanic ash, is used in the invention that concerns us as a binder and in order to keep the zirconium and magnetite particles contained in the final compound in uniform suspension. , preventing said elements from settling in the lower part.
- a zirconium silicate of optimum quality is obtained, and must be free of any foreign material, said zirconium silicate It is combined with the bentonite, taking care not to isolate the natural energy of the zirconium, always ensuring that the bentonite is an adjuvant, perfectly aligned pure magnetite is added taking care that it is kept in suspension between the zirconium, the liquid and the binder material.
- Said mixture is passed through a mill that will be used to pulverize, amalgamate and homogenize the product.
- the mixture obtained should stand 24 hours in a temperature environment between 10 ° C and 25 ° C. Once the mixture is settled, it is passed through an energy meter, until it gives the exact energy pattern necessary for product optimization. Once the energy field is energized and standardized, the mixture is packed in plastic bags.
- the optimal compound will be the following: the percentages to be used in the compound in question will be 10% Magnetite, 70% of Zirconium and 20% solution of bentonite dissolved in drinking water with 80% salt.
- Magnetite from 5% to 15%
- Zirconium from 60% to 80%
- Binder Solution from 15% to 25%
- the amount of compound in a single package will depend on the weight of the person subject to the treatment. In a person of medium complexion, that is to say a person of 1.75 Mts. high and weighing 75 kg. a package containing a minimum of 600 grams of compound should be used. Properties of the invention.
- the properties of the invention are highly curative of any disease or discomfort, since by transmitting the contained and aligned magnetic energy, the magnetic field of the person being treated is properly aligned thus satisfying the energy needs.
- the zirconium in combination with the magnetite transmit, by body contact, the sufficient magnetic energy in order to restore health.
- the combination of magnetite and zirconium also make a receptor compound of the negative energy contained in our body, thus freeing us from discomfort and / or disease, regardless of the pathology in question.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Water Treatment By Electricity Or Magnetism (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/MX2004/000039 WO2005123187A1 (es) | 2004-06-21 | 2004-06-21 | Compuesto de circonio y magnetita para tratamiento energetico |
MXJL06000020A MXJL06000020A (es) | 2004-06-21 | 2006-04-21 | Compuesto de zirconio y magnetita para tratamiento energetico. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/MX2004/000039 WO2005123187A1 (es) | 2004-06-21 | 2004-06-21 | Compuesto de circonio y magnetita para tratamiento energetico |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005123187A1 true WO2005123187A1 (es) | 2005-12-29 |
Family
ID=35509475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/MX2004/000039 WO2005123187A1 (es) | 2004-06-21 | 2004-06-21 | Compuesto de circonio y magnetita para tratamiento energetico |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005123187A1 (es) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4098725A (en) * | 1974-11-28 | 1978-07-04 | Tokyo Denki Kagaku Kogyo Kabushiki Kaisha | Low thermal expansive, electroconductive composite ceramics |
US6217505B1 (en) * | 1995-02-23 | 2001-04-17 | Shinfuji Kogyo Kabushiki Kaisha | Medical fabric goods |
US6652446B1 (en) * | 1992-01-21 | 2003-11-25 | Anthony Bove | Deep heating magnetic wrap for joints and tissue |
-
2004
- 2004-06-21 WO PCT/MX2004/000039 patent/WO2005123187A1/es active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4098725A (en) * | 1974-11-28 | 1978-07-04 | Tokyo Denki Kagaku Kogyo Kabushiki Kaisha | Low thermal expansive, electroconductive composite ceramics |
US6652446B1 (en) * | 1992-01-21 | 2003-11-25 | Anthony Bove | Deep heating magnetic wrap for joints and tissue |
US6217505B1 (en) * | 1995-02-23 | 2001-04-17 | Shinfuji Kogyo Kabushiki Kaisha | Medical fabric goods |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
García et al. | Enfermería de práctica avanzada: historia y definición | |
Bala et al. | Investigation of anti-bacterial activity and cytotoxicity of calcium fluoride nanoparticles | |
US11484694B2 (en) | Magnetic injection of therapeutic agents by addition of material extrusions with differing magnetization and magnetic permeability | |
Singh et al. | Magnetic and structural properties of CaO–SiO2–P2O5–Na2O–Fe2O3 glass ceramics | |
WO2005123187A1 (es) | Compuesto de circonio y magnetita para tratamiento energetico | |
Sulaiman et al. | Antibacterial activity of cobalt ferrite (CoFe2O4) nanoparticles against oral enterococci | |
ES2280645T3 (es) | Uso de zeolitas para la preparacion de composiciones orales para el tratamiento de envenenamiento. | |
JP3021225U (ja) | 健康装身具 | |
Baker et al. | Servicios psiquiátricos y arquitectura | |
Awad et al. | Magnetic Treatment of Water: Properties and Prevention of the Growth of Bacteria | |
JP3024623U (ja) | 健康時計バンド | |
Sen | Bio-friendly magnetic water is ecofriendly | |
Avram et al. | In vitro antibacterial effect of forsterite nanopowder: synthesis and characterization | |
Calduch et al. | Combined radiochemotherapy in localised small-cell lung cancer. Concurrent treatment protocols? | |
Brady et al. | The role of sediment in transmission of channel catfish virus disease | |
Caro et al. | Preparation and comparative biological study of 3-chloro-mercury-2-methoxi-propilurea (CMMP) and 3-acetato-mercury-2-methoxi-propilurea (AMMP) labelled with radiomercury | |
Rosa | Total diet study applied in the evaluation of ingestion of essential, toxic elements, and natural radionuclides in the urban and rural populations of Poços de Caldas | |
Gilbert | Guía práctica para una posible escenificación de El sitio de Bredá (¿ 1627?) de Calderón de la Barca. Hacia una resolución pragmática de los conflictos | |
Kasereka | Awareness-raising through theatre | |
Nowotny et al. | sup (113m) In EDTMP | |
WO2012146217A2 (es) | Proceso de obtención de agua magnetizada y aparato | |
Poblete | La Red Educacional Ignaciana: Un Desafio para Nuestros Suenos | |
Rodriguez T et al. | Immobilization of Co {sup 2+} and Cs {sup+} in zeolites by thermal treatment and by combustion; Inmovilizacion de Co {sup 2+} y Cs {sup+} en zeolitas por tratamiento termico y por combustion | |
Thoreau | El Universo | |
ES1238105U (es) | Envoltura corporal con lastre removible. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: JL/a/2006/000020 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 04748558 Country of ref document: EP Kind code of ref document: A1 |